Brief: Pangaea Oncology Signs 1.1 Mln contract with In3BIO
July 8 (Reuters) - Pangaea Oncology SA PANGO.MC :
* SIGNED 1.1 MILLION EUROS CONTRACT WITH IN3BIO LIMITED TO
CARRY
OUT CLINICAL TRIAL OF ITS LUNG CANCER VACCINE (IN01) APPLIED TO
COVID19
* DEAL INCLUDES SOME VARIABLE MILESTONES UP TO 400,000 EUROS
Source text: https://bit.ly/2BGkxXt
Further company coverage: PANGO.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))